Bergel E, Carroli G, Althabe F
Latin American Center for Perinatology (PAHO-WHO), Casilla de Correo 627, Montevideo, Uruguay, 11000.
Cochrane Database Syst Rev. 2002;2002(2):CD001231. doi: 10.1002/14651858.CD001231.
Hypertensive disorders are among the most common medical complications of pregnancy and a leading cause of maternal and perinatal morbidity and mortality world-wide. Blood pressure measurement plays a central role in the screening and management of hypertension during pregnancy. In recent years the validity of conventional (clinic) blood pressure measurement has been questioned and efforts have been made to improve the technique with ambulatory automated devices that provide a large number of measurements over a period of time, usually a 24-hour period.
To assess whether the use of ambulatory blood pressure monitoring during pregnancy improves subsequent maternal and feto-neonatal outcomes, women-newborn quality of life or use of health service resources, compared with conventional (clinic) blood pressure measurements. These effects will be assessed for the following subgroups: (1) Women at low or average risk of hypertensive disorders of pregnancy (unselected). (2) Women defined as high risk of hypertensive disorders of pregnancy. (3) Women with hypertension without other signs of pre-eclampsia. (4) Women with established pre-eclampsia.
The Cochrane Pregnancy and Childbirth Group trials register, the Cochrane Controlled Trials Register, MEDLINE, LILACS and EMBASE were searched. Date of last search: July 2001.
All randomised trials comparing ambulatory blood pressure monitoring versus conventional (clinic) blood pressure monitoring in pregnancy. Quasi-random designs will be excluded.
Two reviewers evaluated all potentially relevant articles, examined each study for possible inclusion and assessed the methodological quality using the Cochrane guidelines.
No trials included.
REVIEWER'S CONCLUSIONS: There is no randomised controlled trial evidence to support the use of ambulatory blood pressure monitoring during pregnancy. Randomized trials with adequate design and sample sizes are needed to evaluate the possible advantages and risks of ambulatory blood pressure monitoring during pregnancy, in particular in hypertensive pregnant women. These trials should evaluate not only clinical outcomes, but also use of health care resources and women's views.
高血压疾病是妊娠最常见的医学并发症之一，也是全球孕产妇和围产期发病及死亡的主要原因。血压测量在孕期高血压的筛查和管理中起着核心作用。近年来，传统（诊室）血压测量的有效性受到质疑，人们已努力通过动态自动设备改进该技术，这类设备可在一段时间内（通常为24小时）提供大量测量数据。
与传统（诊室）血压测量相比，评估孕期使用动态血压监测是否能改善随后的孕产妇及胎儿 - 新生儿结局、母婴生活质量或卫生服务资源的使用情况。将针对以下亚组评估这些影响：（1）妊娠高血压疾病低风险或中等风险女性（未筛选）。（2）被定义为妊娠高血压疾病高风险的女性。（3）患有高血压但无其他子痫前期体征的女性。（4）已确诊子痫前期的女性。
检索了Cochrane妊娠与分娩组试验注册库、Cochrane对照试验注册库、MEDLINE、LILACS和EMBASE。最后检索日期：2001年7月。
所有比较孕期动态血压监测与传统（诊室）血压监测的随机试验。准随机设计将被排除。
两名评价员评估所有潜在相关文章，审查每项研究以确定是否可能纳入，并根据Cochrane指南评估方法学质量。
未纳入试验。
尚无随机对照试验证据支持孕期使用动态血压监测。需要设计合理且样本量充足的随机试验来评估孕期动态血压监测的潜在优势和风险，尤其是在高血压孕妇中。这些试验不仅应评估临床结局，还应评估卫生保健资源的使用情况和女性的观点。
